Research
Hormonal
Phytoecdysteroids (plant-derived ecdysteroids) do not produce anabolic effects in humans comparable to Anabolic-Androgenic Steroids (AAS), despite structural similarities, likely due to poor bioavailability and lack of specific receptor affinity in human muscle tissue.
Do not expect phytoecdysteroid supplements to build muscle like anabolic steroids. While they share structural similarities, current evidence suggests they do not exert the same anabolic effects in humans, likely due to how the body metabolizes them.
ModerateRefutesMEDIUM confidence
Phytoecdysteroids and Anabolic-Androgenic Steroids - Structure and Effects on Humans
Why this rating
This appears to be a review paper comparing structures and effects; specific human clinical trial data may be sparse or negative in the source text provided.
Source
Phytoecdysteroids and Anabolic-Androgenic Steroids - Structure and Effects on Humans
Mária Báthori et al. · Current Medicinal Chemistry · 2008
DOI 10.2174/092986708783330674
narrative_reviewCited 196×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →